NCT06433817 Spectral CT in Radiotherapy for Cervical Cancer
| NCT ID | NCT06433817 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | Cervical Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-05-22 |
| Primary Completion | 2026-05-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-05-22 with a primary completion date of 2026-05-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study was to explore the potential application of spectral CT for radiotherapy in cervical cancer.
Eligibility Criteria
Inclusion Criteria: 1. All patients were confirmed cervical cancer by pathology 2. patients were treated with concurrent chemoradiotherapy 3. Spectral CT scans acquisition performed during the arterial phase and venous phase 4. All the patients underwent a 18F-FDG PET/CT before treatment Exclusion Criteria: 1. CT without spectral scans 2. History of allergy to intravenous contrast 3. Pregnant or potentially pregnant female subjects
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06433817 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Cervical Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06433817 currently recruiting?
Yes, NCT06433817 is actively recruiting participants. Contact the research team at zhangfq@pumch.cn for enrollment information.
Where is the NCT06433817 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06433817 clinical trial?
NCT06433817 is sponsored by Peking Union Medical College Hospital. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.